[{"AccountsPayableCurrent_0_Q2_USD":13144000.0,"OtherIncome_2_Q2_USD":1937000.0,"OtherIncome_1_Q2_USD":965000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":2669000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":3584000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_2_Q2_USD":-2341000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1_Q2_USD":-725000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_2_Q2_USD":328000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_1_Q2_USD":2859000.0,"OtherAssetsNoncurrent_0_Q2_USD":58652000.0,"OperatingIncomeLoss_2_Q2_USD":97917000.0,"OperatingIncomeLoss_1_Q2_USD":53720000.0,"OperatingExpenses_2_Q2_USD":432231000.0,"OperatingExpenses_1_Q2_USD":226103000.0,"NumberOfReportableSegments_2_Q2_pure":1.0,"NonoperatingIncomeExpense_2_Q2_USD":729000.0,"NonoperatingIncomeExpense_1_Q2_USD":590000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":68855000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":38234000.0,"NetIncomeLoss_2_Q2_USD":68855000.0,"NetIncomeLoss_1_Q2_USD":38234000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":58817000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-4582000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-102136000.0,"LiabilitiesCurrent_0_Q2_USD":153000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":591449000.0,"InvestmentIncomeInterest_2_Q2_USD":1439000.0,"InvestmentIncomeInterest_1_Q2_USD":679000.0,"OtherLiabilitiesCurrent_0_Q2_USD":139856000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":15020000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-73000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-689000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":20771000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":20446000.0,"StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0_Q2_USD":50845000.0,"StockRepurchasedAndRetiredDuringPeriodValue_2_Q2_USD":99155000.0,"StockRepurchasedAndRetiredDuringPeriodValue_1_Q2_USD":29701000.0,"StockRepurchasedAndRetiredDuringPeriodShares_2_Q2_shares":1025000.0,"StockRepurchasedAndRetiredDuringPeriodShares_1_Q2_shares":304000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":0.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":0.0,"StockholdersEquity_0_Q2_USD":418623000.0,"ShareBasedCompensation_2_Q2_USD":7585000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":143873000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":72240000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":8632000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":644813000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":365650000.0,"RepaymentsOfLinesOfCredit_2_Q2_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":97849000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_2_Q2_USD":15000.0,"ProceedsFromLinesOfCredit_2_Q2_USD":0.0,"ProceedsFromIncomeTaxRefunds_2_Q2_USD":0.0,"ProceedsFromHedgeInvestingActivities_2_Q2_USD":0.0,"ProceedsFromCollectionOfNotesReceivable_2_Q2_USD":104000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":26551000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":3146000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":2981000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":99155000.0,"PaymentsForHedgeInvestingActivities_2_Q2_USD":1555000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":336837000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":27185000.0,"InventoryNet_0_Q2_USD":89587000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":53770000.0,"DeferredIncomeTaxesAndTaxCredits_2_Q2_USD":-5775000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":5486000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":114665000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":57014000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":15449000.0,"ContractWithCustomerLiability_0_Q2_USD":16897000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":71524000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":41818000.0,"CommonStockValue_0_Q2_USD":20000.0,"CommonStockSharesOutstanding_0_Q2_shares":20134000.0,"CommonStockSharesIssued_0_Q2_shares":20134000.0,"CommonStockSharesAuthorized_0_Q2_shares":50000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":4806000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-47386000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":268551000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":265368000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":453000.0,"AssetsCurrent_0_Q2_USD":381506000.0,"Assets_0_Q2_USD":591449000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":58000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":59000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":7585000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3845000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":2981000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":116000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":53909000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-956000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":268551000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":20247000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":6511000.0,"DerivativeLossOnDerivative_2_Q2_USD":1555000.0,"InterestPaidNet_2_Q2_USD":5000.0,"InterestExpense_2_Q2_USD":21000.0,"InterestExpense_1_Q2_USD":16000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":30489000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":201000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":199000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2711000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":-14946000.0,"IncreaseDecreaseInInventories_2_Q2_USD":254000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-5030000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":29791000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":16076000.0,"IncomeTaxesPaid_2_Q2_USD":38791000.0,"DerivativeLossOnDerivative_1_Q2_USD":1555000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":98646000.0,"GrossProfit_2_Q2_USD":530148000.0,"GrossProfit_1_Q2_USD":279823000.0,"Goodwill_0_Q2_USD":17467000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":-45000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_2_Q2_USD":0.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_1_Q2_USD":0.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":515000.0,"EarningsPerShareDiluted_2_Q2_USD":3.31,"EarningsPerShareDiluted_1_Q2_USD":1.87,"EarningsPerShareBasic_2_Q2_USD":3.35,"EarningsPerShareBasic_1_Q2_USD":1.89,"DerivativeNumberOfInstrumentsHeld_0_Q2_pure":0.0,"DerivativeNotionalAmount_0_Q2_USD":98684000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":54310000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":20570000.0,"Ticker":"USNA","CIK":"896264","name":"USANA HEALTH SCIENCES INC","OfficialName":"USANA Health Sciences Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2022.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1545888622.0","Country":"United States","Sector":"nan","Industry":"nan","Market":"NYSE","SP500":"nan","filed":"20210811"}]